As the functional roles of the two representative signature genes SLC16A3 and EGR2 in lung adenocarcinoma progression remain incompletely elucidated, we selected them for expression and functional validation using a series of in vitro assays. This evidence concerns the gene SLC16A3 and lung adenocarcinoma.